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The independently folded appendages of the large ␣ and ␤2 subunits of the endocytic adaptor protein (AP)-2 complex
coordinate proper assembly and operation of endocytic components during clathrin-mediated endocytosis. The ␤2
subunit appendage contains a common binding site for ␤-arrestin or the autosomal recessive hypercholesterolemia (ARH)
protein. To determine the importance of this interaction surface in living cells, we used small interfering RNA-based gene
silencing. The effect of extinguishing ␤2 subunit expression on the internalization of transferrin is considerably weaker
than an AP-2 ␣ subunit knockdown. We show the mild sorting defect is due to fortuitous substitution of the ␤2 chain with
the closely related endogenous ␤1 subunit of the AP-1 adaptor complex. Simultaneous silencing of both ␤1 and ␤2
subunit transcripts recapitulates the strong ␣ subunit RNA interference (RNAi) phenotype and results in loss of ARH
from endocytic clathrin coats. An RNAi-insensitive ␤2-yellow fluorescent protein (YFP) expressed in the ␤1 ⴙ ␤2-silenced
background restores cellular AP-2 levels, robust transferrin internalization, and ARH colocalization with cell surface
clathrin. The importance of the ␤ appendage platform subdomain over clathrin for precise deposition of ARH at clathrin
assembly zones is revealed by a ␤2-YFP with a disrupted ARH binding interface, which does not restore ARH
colocalization with clathrin. We also show a ␤-arrestin 1 mutant, which engages coated structures in the absence of any
G protein-coupled receptor stimulation, colocalizes with ␤2-YFP and clathrin even in the absence of an operational
clathrin binding sequence. These findings argue against ARH and ␤-arrestin binding to a site upon the ␤2 appendage
platform that is later obstructed by polymerized clathrin. We conclude that ARH and ␤-arrestin depend on a privileged
␤2 appendage site for proper cargo recruitment to clathrin bud sites.

INTRODUCTION
Clathrin-mediated endocytosis is a process through which
many nutrient and signaling receptors, ion channels, and
even pathogens, are internalized from the cell surface and
delivered to endosomes. The process requires the fine coor-
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dination of cargo selection, membrane invagination, and
actin dynamics (Conner and Schmid, 2003; Robinson, 2004;
Edeling et al., 2006b; Kaksonen et al., 2006). At the plasma
membrane, these diverse processes are managed, in part, by
the adaptor protein (AP)-2 heterotetramer. The brick-like
AP-2 core is composed of a small 2 subunit, the cargoselective 2 subunit, along with the N-terminal trunks of
two large chains, the ␣ and ␤2 subunits (Collins et al., 2002;
see Figure 4A). Projecting off both ␣ and ␤2 subunit trunks,
via flexible hinges, are bilobal appendages that contain
binding sites for clathrin and numerous other endocytic
proteins (Robinson, 2004; Edeling et al., 2006b; Schmid
and McMahon, 2007).
The four assembled subunits permit AP-2 to coordinate
various aspects of clathrin coat formation. The plasma membrane-enriched lipid phosphatidylinositol 4,5-bisphosphate
[PtdIns(4,5)P2] is engaged by both the ␣ and 2 subunits
(Gaidarov and Keen, 1999; Höning et al., 2005). YXXØ-type
sorting signals (as found in the transferrin receptor) are
bound directly by the 2 subunit (Ohno et al., 1995), whereas
[DE]XXXL[LIM] dileucine signals are recognized by a functional hemicomplex of the ␣ and 2 subunit (Janvier et al.,
2003; Coleman et al., 2005; Chaudhuri et al., 2007). Various
assembly protein and clathrin associations are established
through the ␣ and ␤2 appendages (Wang et al., 1995;
McPherson and Ritter, 2005; Traub, 2005; Edeling et al.,
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2006b; Schmid and McMahon, 2007). The ␣ appendage has
two interaction surfaces, one each upon the platform and
sandwich subdomains. The platform site can bind to
DP[WF] and FXDXF interaction motifs (Brett et al., 2002;
Praefcke et al., 2004), whereas the sandwich site engages the
WXX[FW]Xn[DE] motif (Mishra et al., 2004; Praefcke et al.,
2004; Ritter et al., 2004; Walther et al., 2004). These short
interaction sequences are typically positioned within tracts
of intrinsically unstructured polypeptide, and proteins bearing the former class of motifs are typically involved in cargo
selection and lattice polymerization. Proteins bearing the
latter set generally include regulatory proteins such as adaptor-associated kinase 1, cyclin G-dependent kinase, and the
phosphoinositide polyphosphatase synaptojanin 1 (Jha et al.,
2004; Praefcke et al., 2004; Walther et al., 2004). Some of the
regulatory proteins, such as synaptojanin 1, also contain
platform binding sites, potentially allowing them to compete
previously bound clathrin-associated sorting proteins
(CLASPs) off AP-2 (Mishra et al., 2004; Praefcke et al., 2004).
Thus, the ␣ appendage regulates the temporal organization
of the developing clathrin lattice through binding sites that
permit the recruitment of first lattice assembly and cargo
selective factors, followed by regulatory proteins that control bud formation and likely promote release of proteins
from AP-2 once their role in endocytosis is complete.
Similar to the ␣ appendage, the structurally related ␤2
appendage also contains two interaction surfaces, one surface analogous to the ␣ appendage-platform site, and one
surface positioned on the opposite side from the cognate ␣
appendage-sandwich site (Edeling et al., 2006a; Schmid et al.,
2006). The contact sites on the ␤2 appendage do not seem to
control accessory proteins in precisely the same manner as
the hierarchical ␣ appendage binding sites. Biochemical
studies suggest the ␤2 appendage-platform site is largely
dedicated to CLASPs, such as the ␤-arrestins, which concentrate G protein-coupled receptors (GPCRs) (Kim and
Benovic, 2002; Laporte et al., 2002; Milano et al., 2002); the
autosomal recessive hypercholesterolemia (ARH) protein,
which decodes the FXNPXY-type sorting signal (He et al.,
2002; Mishra et al., 2002b); and epsin 1, which recognizes
poly/multiubiquitinated cargo (Barriere et al., 2006; Hawryluk
et al., 2006). These discrete classes of cargo internalization
signal do not bind directly to AP-2. The ␤2 appendagesandwich site, along with a type I clathrin box in the ␤2hinge, allows AP-2 to polymerize clathrin and regulate
eps15 positioning within the assembling lattice (Cupers et
al., 1998; Owen et al., 2000; Edeling et al., 2006a). Thus, the ␤2
subunit contains functionally distinct binding sites that
could simultaneously allow privileged access of certain
CLASPs to the lattice along with clathrin recruitment. Overall, AP-2 acts as a master adaptor, binding to the plasma
membrane, sorting YXXØ- and [DE]XXXL[LIM]-bearing
cargo, and coordinating clathrin vesicle formation while
simultaneously providing access for alternative types of
cargo by scaffolding CLASPs. Accordingly, targeted gene
disruption or mutation of AP-2 2 or ␣ subunit genes is
homozygous lethal in mice (Mitsunari et al., 2005), Drosophila
(Gonzalez-Gaitan and Jackle, 1997), and Caenorhabditis elegans (Shim and Lee, 2000).
In humans, inherited deficiency of one CLASP, ARH,
results in a pathological hypercholesterolemia similar to, but
less severe than, familial hypercholesterolemia (Eden et al.,
2001; Garcia et al., 2001). Structurally, ARH contains a phosphotyrosine binding (PTB) domain that binds simultaneously to both FXNPXY peptides and PtdIns(4,5)P2 and an
unstructured C terminus containing a type I clathrin box
and the ␤2 appendage-binding sequence (Eden et al., 2002;
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He et al., 2002; Mishra et al., 2002b). Functionally, it may play
an analogous role to the ␤-arrestins, which use a related,
helical [DE]nX1-2FXX[FL]XXXR ␤2-binding sequence to
usher GPCRs to preformed clathrin coats (Laporte et al.,
2000; Kim and Benovic, 2002; Milano et al., 2002; Edeling et
al., 2006a; Hamdan et al., 2007). ARH may likewise use
primarily the ␤2 appendage-binding site, rather than the
clathrin box, to shuttle or retain low density lipoprotein
(LDL) receptors in clathrin structures.
To test ARH dependence on ␤2 appendage binding, we
replaced endogenous AP-2 ␤2 subunits with various ␤2yellow fluorescent protein (YFP) mutants by using RNA
interference (RNAi). When characterizing the ␤2 subunit
knockdown necessary for this approach, we found that simultaneous depletion of the ␤1 subunit from the related
trans-Golgi network (TGN)/endosome-localized AP-1 complex is also necessary, because, otherwise, the highly related,
endogenous ␤1 subunit compensates for ␤2 subunit depletion. In the context of a ␤1 ⫹ ␤2 subunit knockdown, the ␤2
subunit trunk is sufficient to rescue known AP-2 knockdown
phenotypes (Hinrichsen et al., 2003; Motley et al., 2003),
clustering transferrin in clathrin coats and restoring cellular
AP-2 levels, although ARH surface localization is clearly
disrupted. Rescue of the ␤1 ⫹ ␤2 subunit knockdown with
a full-length ␤2-YFP bearing a point mutation in the ␤2platform subdomain also fails to recover ARH localization to
clathrin structures, whereas both wild-type ␤2-YFP or ␤2YFP lacking clathrin binding sites restore ARH localization
to clathrin puncta. This suggests that AP-2 is vital both as the
YXXØ-selective CLASP and as a scaffold controlling endocytic protein recruitment to clathrin-coated pits during endocytosis.
MATERIALS AND METHODS
Plasmids, Small Interfering RNA (siRNA) and Antibodies
The siRNA duplexes used target base pairs 1384-1402 of the human ␤2
subunit (Huang et al., 2004) (Dharmacon RNA Technologies, Lafayette, CO),
base pairs 1529-1537 of the human ␤1 subunit (Invitrogen, Carlsbad, CA or
Dharmacon RNA Technologies), and base pairs 1052-1069 of the ␣ subunit
transcript (Dharmacon RNA Technologies) (Keyel et al., 2006). All siRNA
oligonucleotides were synthesized with dTdT overhangs. The ␤2-YFP plasmid was a kind gift from Alexander Sorkin (University of Colorado at
Denver, Aurora, CO; Sorkina et al., 2002). Generation of the ␤2-YFP mutants
and truncation has been described previously (Keyel et al., 2006). The tandem
dimer tomato (tdRFP)-␤-arrestin 1 was generated by first replacing enhanced
green fluorescent protein (EGFP) with tdRFP (Shaner et al., 2004) between the
NheI and BspE1 restriction sites in pEGFP-C1, followed by insertion of
full-length Bos taurus ␤-arrestin 1 between XhoI and SalI sites. The ␤2-YFP
platform (Y888V) and sandwich (Y815A) subdomain mutants, the clathrinbox deleted (⌬LLDLD) mutant, the tdRFP-␤-arrestin 1 paired I386A and
V387A (IV3 AA) constitutively active mutant, and the clathrin box
376
LIEL3 AAEA mutation or clathrin-box-deleted ⌬LIELD were all generated
using QuikChange mutagenesis (Stratagene, La Jolla, CA).
The anti-clathrin heavy chain (HC) monoclonal antibody (mAb) TD.1
(Nathke et al., 1992) and X22 (Brodsky, 1985), the AP-1/2 ␤1/␤2 subunit mAb
100/1 (Ahle et al., 1988) and affinity-purified antibody GD/1 (Traub et al.,
1999), the AP-2 ␣ subunit mAb AP.6 (Chin et al., 1989), the anti-AP-1 ␥ subunit
antibody AE/1 (Traub et al., 1995), the anti-AP-1 1 subunit antibody RY/1
(Traub et al., 1995), the anti-ARH antibody (Mishra et al., 2002b), the antication–independent mannose 6-phosphate receptor (MPR) antibody (Zhu et
al., 1999), the anti-epsin 1 polyclonal antibody (Drake et al., 2000), and the
anti-disabled-2 (Dab2) polyclonal antibody (Mishra et al., 2002a) have been
described previously. Affinity-purified anti-eps15 polyclonal was kindly provided by Ernst Ungewickell (Medizinische Hochschule Hannover, Hannover,
Germany; Hinrichsen et al., 2003). The anti-transferrin receptor mAb H68.4
was a gift from Ian Trowbridge (The Salk Institute, La Jolla, CA; White et al.,
1992), rabbit R11-29 anti-AP-2 2 subunit serum was kindly provided by Juan
Bonifacino (National Institutes of Health, Bethesda, MD; Aguilar et al., 1997),
the anti-lysosome–associated membrane protein (LAMP)-1 mAb G1/139 was
kindly provided by Jack Rohrer (Zürcher Hochschule für Angewandte Wissenschaften, Wadenswil, Switzerland; Rohrer et al., 1996), and anti-green
fluorescent protein (GFP) polyclonal antibody B5 was generously provided by
Phyllis Hanson (Washington University School of Medicine, St. Louis, MO;
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Dalal et al., 2004). Anti-AP-2 ␣ subunit mAb clone 8 and the anti-AP-1 ␥
subunit mAb clone 88 were both from BD Biosciences Transduction Laboratories (Lexington, KY). The anti-␤-arrestin polyclonal antibody was purchased from Sigma-Aldrich (St. Louis, MO), the anti-tubulin mAb E7 was
from the Developmental Studies Hybridoma Bank (University of Iowa, Iowa
City, IA), and a hybridoma secreting anti-LDL receptor mAb IgG-C7 was
from the American Type Culture Collection (Manassas, VA). Horseradish
peroxidase-conjugated donkey anti-mouse and anti-rabbit, Cy5-conjugated
goat anti-mouse, and 15-nm gold-conjugated anti-mouse secondary antibodies were purchased from Jackson ImmunoResearch Laboratories (West Grove,
PA), whereas Alexa Fluor 488 angiotensin II, Alexa Fluor 488-, and Alexa
Fluor 568-conjugated goat anti-mouse and anti-rabbit secondary antibodies
were obtained from Invitrogen.

Cell Culture, RNAi, and Reconstitution
HeLa SS6 cells (Elbashir et al., 2001) were cultured at 37°C humidified with 5%
CO2 in DMEM supplemented with 10% fetal calf serum and 2 mM l-glutamine (Invitrogen). A line of HeLa SS6 cells stably expressing ␤2-YFP was
selected in the same medium supplemented with 0.5 mg/ml G-418 (Invitrogen). Analysis of these cells shows that ⬍10% of cellular AP-2 contains the
YFP-tagged ␤2 subunit. Wild-type (⫹/⫹) and AP-2 ␤2 subunit homozygous
mutant (␤2 ⫺/⫺) mouse embryonic fibroblasts were cultured in DMEM
supplemented with 10% fetal calf serum, 2 mM l-glutamine, and 1⫻ antibiotic/antimycotic mixture (Sigma-Aldrich). ␤-Arrestin nullizygous mouse embryonic fibroblasts were kindly provided by Robert Lefkowitz (Kohout et al.,
2001). Cells were maintained in DMEM supplemented with 10% fetal calf
serum and 2 mM l-glutamine. Human embryonic kidney (HEK) 293 cells
stably expressing a FLAG-tagged type I angiotensin II receptor were kindly
provided by Stéphane Laporte (McGill University, Montreal, Quebec, Canada), and they were cultured in Earle’s minimal essential medium. RNAi and
reconstitution were performed as described previously (Keyel et al., 2006). For
rescue experiments, 100 ng of rescue DNA was included along with the
siRNA duplexes at the time of transfection and did not block RNAi-mediated
knockdown of the targeted proteins (Supplemental Figure S2).

Immunofluorescence
HeLa SS6 cells were prepared for immunofluorescence as described previously (Mishra et al., 2005). To visualize only the plasma membrane associated
clathrin, or only AP-2 with the anti-␤1/␤2 antibody GD/1, cells were treated
with 10 g/ml brefeldin A (Epicenter Technologies, Madison, WI) for 15 min,
followed by permeabilization in 0.3% saponin, 25 mM HEPES-KOH, pH 7.2,
125 mM potassium acetate, and 5 mM magnesium acetate for 1 min on ice
before fixation to remove cytosolic and ARF-dependent clathrin and AP-1. For
experiments involving LDL receptors, the cells were grown in DMEM supplemented with 10% lipoprotein-deficient serum (Cocalico Laboratories,
Reamstown, PA), 2 mM l-glutamine for 24 – 48 h to up-regulate LDL receptors, whereas for experiments involving transferrin, cells were placed in
DMEM supplemented with 25 mM HEPES-KOH, pH 7.2, and 0.5% bovine
serum albumin (starvation medium) for 1 h before experiments to unload the
receptors. To measure surface levels of receptors, cells were incubated with
either the appropriate antibody or 25 g/ml transferrin conjugated to Alexa
Fluor 568 (Tf568) (Invitrogen) in starvation medium for 1 h on ice at 4°C and
fixed for immunofluorescence. To measure the amount of internalized receptors, cells were either incubated on ice as described above and then washed
and warmed to 37°C for 15 min before fixation (see Figures 1 and 7); or after
the 1 h in starvation medium, maintained in the continuous presence of 25
g/ml Tf568 or 50 g/ml Tf633 (Invitrogen) for 15 min at 37°C before fixation
(see Figures 6 and 7). Alexa 488-labeled angiotensin II (100 nM) was added at
37°C for 5 or 20 min. For imaging of surface transferrin receptor-labeled
fibroblasts, 25 g/ml Tf488 was bound at 4°C for 1 h in starvation media.
Cells were washed once and imaged at 4°C in starvation media using a
temperature-controlled stage mount (Harvard Apparatus, Holliston, MA).

Immunoprecipitation
HeLa SS6 cells grown in six-well plates, treated or untreated with siRNA
against ␤2 subunit as described above, were trypsinized, washed in phosphate-buffered saline (PBS), and lysed in 10 mM HEPES-KOH, pH 7.2, 0.3 M
sucrose, 1% Triton X-100, and Complete mini-protease inhibitor cocktail
(Roche Diagnostics, Mannheim, Germany) for 30 min on ice. Cell debris was
removed by centrifugation at 18,000 ⫻ gmax for 10 min at 4°C, and the
supernatants frozen on dry ice and stored at ⫺80°C until use. The samples
were thawed and incubated with 2 g of anti-␣ subunit mAb AP.6 for 1 h at
4°C with gentle shaking, followed by the addition of protein G-coupled beads
(Sigma-Aldrich), an additional hour at 4°C with gentle shaking, and then
centrifugation to separate supernatant from pellet. The pellets were washed
extensively in PBS and 1% Triton X-100, and then they were mixed with SDS
sample buffer such that one-eighth of the pellet and ⬃1/25 of the supernatant
were analyzed by SDS-polyacrylamide gel electrophoresis (PAGE). AP-2 was
similarly immunoprecipitated from lysates of embryonic fibroblasts prepared
in 10 mM HEPES-KOH, pH 7.2, 0.3 M sucrose, 500 mM Tris-HCl, 1% Triton
X-100, Complete mini-protease inhibitor cocktail, and 1 mM phenylmethylsulfonyl fluoride. After centrifugation to remove insoluble material, lysates
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were diluted fourfold before addition of 5 g of mAb AP.6. Electrophoresis
and immunoblotting was as described previously (Keyel et al., 2006). Blots
were quantitated by measuring the integrated intensity of a fixed region
containing the band in MetaMorph (MDS Analytical Technologies, Sunnyvale, CA), subtracting that intensity from the background in a similarly sized
region, and normalizing expression to clathrin expression. Normalized expression levels were compared with those of mock-transfected cells to determine up- or down-regulation of AP-1 and AP-2 subunits under the various
RNAi conditions.

Microscopy
Images were acquired on a FluoView FV500 or FV1000 confocal microscope
(Olympus, Tokyo, Japan) as described previously (Keyel et al., 2006). Quantitation of ARH clathrin coat localization was performed using MetaMorph
software (MDS Analytical Technologies) by measuring the integrated intensity of ARH staining in cell surface confocal sections that were either control
(normal transferrin internalization), knocked down (blocked transferrin internalization), or rescued (YFP expression) and subtracting the intensity of
knockdown cells from that of either mock transfected or neighboring rescued
cells. The number of clathrin and AP-2 (␣ subunit) puncta were determined
by manually counting all puncta within a 10 ⫻ 10 m (clathrin) or 6 ⫻ 6 m
(AP-2) portion of cells from multiple fields and independent experiments
expressing very low levels of clathrin/AP-2 (AP-2 knocked down cells) or
cells expressing wild-type levels of the protein (mock). Statistical significance
was determined using Student’s t test. Cells with surface transferrin, transferrin uptake or AP-2 (␣ subunit) intensity phenotypes were manually
counted in MetaMorph (MDS Analytical Technologies) as either normal or
impaired, and the total percentage of cells either expressing or not expressing
␤2-YFP determined. Impaired phenotypes consisted of loss of transferrin
localization to coated pits, very low levels of internalized transferrin, or AP-2
␣ subunit intensities on a par with those found with AP-2 ␣ subunit siRNA.
These percentages were averaged for two to three independent experiments
and significance determined using a one-tailed Student’s t test.
Total internal reflection fluorescence microscopy (TIR-FM) was performed
as described previously (Keyel et al., 2004), with some modifications. Images
were collected with a thermoelectrically cooled Cascade II 512 camera (Photometrics, Tucson, AZ). Data sets were collected with MetaMorph software at
⬃1 frame/5 s. For quantification of colocalization of tdRFP-␤-arrestin 1 with
AP-2 in ␤2-YFP– expressing cells, an average of 55 spots/cell in 11-15 individual cells were analyzed.
Adherent plasma membrane from cells treated with ␣ subunit siRNA as
described above were prepared for rapid-freeze, deep-etch electron microscopy as described previously (Heuser, 2000). Briefly, cells grown on small
oriented pieces of glass coverslip were disrupted by sonication, fixed in
paraformaldehyde, and labeled with anti-transferrin receptor mAb H68.4 and
then 15-nm gold-conjugated anti-mouse antibody before flash freezing in
liquid helium (Keyel et al., 2006).

RESULTS
Gene Silencing of the AP-2 ␣ Subunit
In HeLa SS6 cells, we find transfection of siRNA duplexes
targeting the AP-2 ␣ subunit mRNA reduces the protein
level of all four adaptor subunits ⬎75% within 48 h (Figure
1A and Supplemental Figure 1A), in very good agreement
with previous results (Hinrichsen et al., 2003; Motley et al.,
2003). Depletion of AP-2 is also seen morphologically, as a
sharp decrease in the intensity of surface AP-2–positive
puncta compared with the control cells (Figure 1B). It is
known that AP-2 knockdown reduces the amount of clathrin
positioned at the plasma membrane but not that recruited to
other structures or total cytoplasmic amounts (Hinrichsen et
al., 2003; Motley et al., 2003). To selectively visualize clathrin
at the plasma membrane, we briefly treated cells with brefeldin A to dissociate clathrin from internal membrane structures, and then we rapidly permeabilized the cells before
fixation (Figure 1, C and D). In mock-transfected cells, this
treatment effectively eliminates TGN, endosomal and cytosolic clathrin, without perturbing the plasma membrane
associated clathrin pool. No AP-1 ␥ subunit staining is observed, and the remaining ␤ subunit signal is fully sensitive
to ␣ subunit RNAi (Figure 1C). Although the total amount of
clathrin recruited to the plasma membrane is greatly diminished upon AP-2 ␣ subunit RNAi (Figure 1D), we do not
observe that the total number of surface puncta decreases
5311
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Figure 1. siRNA-mediated gene silencing of
the AP-2 ␣ subunit. (A) Lysates of HeLa SS6
cells untreated (lanes a and b) or treated with
AP-2 ␣ subunit siRNA (lanes c and d) were
resolved by SDS-PAGE and either Coomassie
stained or transferred to nitrocellulose. Sections of the blots were probed with anti-AP-2
␣ subunit mAb clone 8, anti-clathrin heavy
chain (HC) mAb TD.1, anti-␤1/␤2 subunit
mAb 100/1, anti-AP-2 2 antiserum, or antitubulin mAb E7, and only the relevant portion
of each blot shown. The position of molecular
mass standards (in kilodaltons) is indicated on
the left. (B–D) HeLa SS6 cells untreated (left)
or treated with AP-2 ␣ subunit siRNA (right)
were treated with 10 g/ml brefeldin A for 15
min, permeabilized on ice for 1 min before
fixation, and prepared for immunofluorescence using the anti-AP-2 ␣ subunit mAb AP.6
(B), anti-AP-1 ␥ subunit mAb (C; green), anti␤1/␤2 subunit antibody GD/2 (C; red), or
anti-clathrin heavy chain mAb X22 (D). (E–G)
HeLa SS6 cells untreated (left) or treated with
AP-2 ␣ subunit siRNA (right) were incubated
on ice for 1 h with either anti-LDL receptor
mAb C7 (E; green), Tf568 (E, red and F), antiLAMP-1 mAb (G; green), or anti-MPR antibody (G; red) and fixed (E and G) or washed
and warmed to 37°C for 15 min and fixed (F)
followed by indirect immunofluorescence.
Bar, 10 m.

⬎10-fold as reported originally (Hinrichsen et al., 2003; Motley et al., 2003). Rather, in ␣ subunit–silenced cells, although
very dim, the number of discrete clathrin- and AP-2– containing surface structures is 73.2 and 70.7% that of control,
respectively. The discrepancy is probably because AP-2
complexes are not completely eliminated under our single
transfection RNAi conditions (Figure 1B).
Extinguishing AP-2 expression also abrogates the clustering of surface receptors bearing a YXXØ internalization
signal, exemplified by the transferrin receptor, at clathrinpositive puncta. Unlike the mock-treated cells, transferrin
marks a population of diffuse receptors on the surface of
AP-2– deficient cells (Figure 1E). Other receptors, such as the
LDL receptor, that bear the FXNPXY-type internalization
signal decoded by the CLASPs ARH and disabled-2 (Dab2),
can internalize in an AP-2–independent manner (Eden et al.,
2002; Garuti et al., 2005; Keyel et al., 2006; Maurer and
Cooper, 2006; Eden et al., 2007). Nonetheless, because Dab2
and ARH each bind physically to both AP-2 and clathrin, in
mock-treated cells, the LDL receptor and transferrin congregate in common surface structures (Figure 1E), which contain clathrin and AP-2 (Keyel et al., 2006). Yet, when AP-2
complexes are extinguished, only the surface distribution of
the transferrin receptor, and not the LDL receptor, alters
dramatically (Figure 1E). A consequence of the dispersion of
the transferrin receptor is that transferrin is very poorly
5312

internalized (Figure 1F). To verify that the internalization
defect is general to proteins bearing the YXXØ signal, we
examined the surface distributions of the MPR and LAMP-1.
The trafficking trajectory of these transmembrane proteins
takes them through the plasma membrane relatively infrequently (Rohrer et al., 1996) and normally, the proteins are
concentrated, at steady state, in endosomes/TGN and lysosomes, respectively. If delivered to the cell surface, both are
retrieved via clathrin-mediated endocytosis (Ghosh et al.,
2003). In the context of ␣ subunit knockdown, and consistent
with both the absolute dependence of the YXXØ signal on
AP-2 for sorting into clathrin-coated vesicles and previous
observations (Harasaki et al., 2005; Janvier and Bonifacino,
2005), a surface population of both the MPR and LAMP-1
becomes readily detectable as they stagnate at the surface
(Figure 1G).
To better understand at the ultrastructural level how the
AP-2 knockdown affects clathrin lattice assembly at the cell
surface, adherent plasma membranes of mock- and ␣ subunit siRNA-treated cells were analyzed by immunogold
freeze-etch electron microscopy. AP-2 knocked down cells
can be unambiguously identified with mAb H68.4. This
antibody detects an epitope located near the amino terminus
of the human transferrin receptor that overlaps with the
YTRF internalization signal (White et al., 1992). Transferrin
receptors positioned within clathrin lattices by engagement
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Figure 2. AP-2 knocked down cell ultrastructure.
HeLa SS6 cells either mock transfected (A) or transfected with ␣ subunit siRNA oligonucleotides (B–D)
were briefly sonicated to prepare cell cortices, fixed,
labeled with anti-transferrin receptor mAb H68.4, and
then 15-nm gold-conjugated anti-mouse secondary antibodies to visualize extra-lattice receptors. Arrows indicate gold-labeled receptors.

of the AP-2 2 subunit are not recognized by this mAb; only
the extra-lattice population of the receptor is detected (White
et al., 1992). In our images, compared with mock-transfected
cells (Figure 2A), the frequency of gold labeling in the AP-2
gene-silenced cells is increased, especially the population
⬎100 nm from assembled clathrin lattices (Figure 2, B–D). In
the siRNA-transfected cells, the discernible clathrin coats are
substantially smaller than normal (Motley et al., 2003), concordant with the immunofluorescence data (Figure 1) and
the capability of CLASPs like Dab2 and epsin to promote
clathrin lattice assembly (Drake et al., 2000; Morris and Cooper, 2001; Kalthoff et al., 2002; Mishra et al., 2002a). Despite
the limited dimensions, both flattened lattices and invaginating buds are visible. Overall, we conclude that the knockdown of the ␣ subunit of AP-2 ablates AP-2 sorting activity
with similar functional consequences as reported initially
(Hinrichsen et al., 2003; Motley et al., 2003), except that our
knockdown procedure does not decrease as dramatically the
total number of surface clathrin-containing structures.
Gene Silencing of the AP-2 ␤2 Subunit Does Not
Inactivate AP-2
Next, as a prelude to evaluating the function of the ␤2
subunit hinge and appendage by reconstitution after AP-2
RNAi, we selectively knocked down the AP-2 ␤2 subunit in
HeLa SS6 cells. Although the ␤2 subunit polypeptide is very
effectively diminished (Huang et al., 2004), in marked contrast to the ␣ subunit RNAi, the abundance of other AP-2
subunits is only mildly affected (Figure 3A and Supplemental Figure S1A). A comparatively weak effect on AP-2 levels
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is also apparent by immunofluorescence. The levels of the ␣,
and, surprisingly, ␤ subunits of AP-2 in the context of a ␤2
subunit knockdown are reduced from normal levels, but
clearly not to the extent observed in an ␣ subunit knockdown (Figure 3B). Likewise, the other phenotypes characteristic of ␣ subunit knockdown are not as penetrant when
using ␤2 subunit siRNA duplexes (Figure 3, C–E). The intensity of clathrin within punctate structures is intermediate
between control and ␣ subunit knockdown, which is likely
due to the presence of functional AP-2 complexes in the cell
(Figure 3C). Also, AP-2– dependent cargo, the MPR and
LAMP-1, do not accumulate appreciably at the cell surface
(Figure 3D), and although the transferrin distribution is
more diffuse over the surface than in mock-transfected cells,
it is also present in numerous puncta on the plasma membrane (Figure 3E). We conclude that AP-2 ␤2 subunit knockdown produces a milder variant of the ␣ or 2 subunit RNAi
phenotype, due to incomplete depletion of AP-2.
The AP-1 ␤1 Subunit Is Incorporated into AP-2 in the
Absence of a ␤2 Subunit
A clue to the biochemical basis for the milder ␤2 RNAi
phenotype comes from the surface ␤ subunit signal in cells
lacking the ␤2 subunit (Figure 3B). The ␤1 and ␤2 subunits
of AP-1 and AP-2 are ⬃85% identical, in contrast to the other
three subunits of the heterotetramers, which display ⬍50%
homology (Figure 4A). The appendages of the ␤1 and ␤2
subunits are structurally homologous and share many binding partners (Owen et al., 2000; Lundmark and Carlsson,
2002; Edeling et al., 2006a; Knuehl et al., 2006; Schmid et al.,
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Figure 3. AP-2 ␤2 subunit gene silencing. (A) Lysates
of HeLa SS6 cells untreated (lane a) or treated with
either AP-2 ␣ or ␤2 subunit siRNA (lanes b and c) were
resolved by SDS-PAGE and either Coomassie stained or
transferred to nitrocellulose. Sections of the blots were
probed with anti-clathrin HC mAb TD.1, anti-AP-2 ␣
subunit mAb clone 8, anti-␤1/␤2 subunit mAb 100/1,
anti-AP-2 2 antiserum, or anti-AP-1 ␥ subunit antibody AE/1, and only the relevant portion of the blots is
shown. The position of molecular mass standards (in
kilodaltons) is indicated on the left. (B and C) HeLa SS6
cells untreated (left) or treated with AP-2 ␣- (middle), or
␤2 subunit siRNA (right) were treated with 10 g/ml
brefeldin A for 15 min, permeabilized on ice for 1 min
before fixation, and prepared for immunofluorescence
using the anti-AP-2 ␣ subunit mAb AP.6 (B, green),
anti-␤1-/␤2 subunit antibody GD/2 (B; red), or anticlathrin HC mAb X22 (C). (D and E) HeLa SS6 cells
untreated (left) or treated with AP-2 ␣ (middle) or ␤2
subunit (right) siRNA were incubated on ice for 1 h with
either anti-LAMP-1 mAb (D; green) and anti-MPR antibody (D; red), or anti-LDL receptor mAb C7 (E; green)
and Tf568 (E; red), fixed, and prepared for indirect
immunofluorescence. The inset in E shows Tf568 immunofluorescence from each sample.

2006). In fact, the Drosophila melanogaster genome encodes
only a single ␤ subunit that is incorporated into both AP-1
and AP-2 (Camidge and Pearse, 1994). Almost all available
antibodies raised against the vertebrate ␤ subunits recognize
both ␤1 and ␤2 subunits, although these subunits can be
resolved by SDS-PAGE (Page and Robinson, 1995; Sorkin et
al., 1995; Traub et al., 1996). Thus, the fluorescent signal
observed in ␤2 subunit-knockdown cells may be due to ␤1
5314

subunit incorporated into AP-2. To test this hypothesis, we
treated HeLa SS6 cells with or without ␤2 subunit siRNA,
and then we immunoprecipitated AP-2 with an ␣ subunitspecific mAb. In mock-transfected cells, the majority of AP-2
is recovered in the immunoprecipitate, and the principal ␤
subunit incorporated into AP-2 is the faster migrating ␤2
chain (Figure 4B). However, when the ␤2 subunit is depleted, this smaller chain almost disappears, and the majorMolecular Biology of the Cell
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Figure 4. ␤1 subunit rescues ␤2 subunit knockdown of AP-2. (A) Schematic diagram of AP-1 and AP-2 complex composition and subunit
homology. (B) Lysates from either untreated or ␤2 siRNA-treated HeLa SS6 cells were prepared and AP-2 immunoprecipitated using the
anti-␣ subunit mAb AP.6. Aliquots of the supernatant and precipitate fractions from both control and ␤2 RNAi samples were resolved by
SDS-PAGE and transferred to nitrocellulose. Blots were probed with the anti-AP-2 ␣ subunit mAb clone 8, anti-␤1/␤2 subunit antibody mAb
100/1, anti-clathrin HC antibody mAb TD.1, or anti-AP-2 2 antiserum, and only the relevant portion of each blot is shown.

ity of the ␤ subunit now assembled into AP-2 is the larger ␤1
subunit (Figure 4B).
Independent verification of the incorporation of the AP-1
␤1 subunit into AP-2 comes from mouse embryonic fibroblasts homozygous for a disrupted ␤2 subunit gene. Like
HeLa SS6 cells, ⫹/⫹ fibroblasts from normal littermate controls display both the ␤1 subunit and the faster migrating ␤2
polypeptide (Figure 5A). The ␤2-null ⫺/⫺ fibroblasts
clearly express only the larger ␤1 polypeptide, and the overall abundance of the AP-2 ␣ and 2 subunits, but not of the
AP-1 1 or 1 subunits, is diminished compared with the
control lysates. AP-2 immunoprecipitated from ⫺/⫺ cells
with an ␣ subunit-specific mAb contains only the ␤1 subunit
(Figure 5A), similar to the ␤2 gene-silenced HeLa SS6 cells.
Likewise, the surface distribution of AP-2, as judged by the
intracellular positioning of the ␣ subunit, is very similar to
the ⫹/⫹ fibroblasts (Figure 5, B–E), despite the reduced
levels of the ␣ and 2 chains in the ⫺/⫺ fibroblasts. The
surface distribution of CLASPs such as Dab2, epsin, and
eps15 is also highly similar to the normal fibroblast controls
(Figure 5, C–E). Therefore, we conclude that because of the
high degree of sequence homology, the ␤1 subunit is promiscuously incorporated into AP-2 when cellular ␤2 subunit
levels are depressed, and that this misassembly largely preserves the functional capabilities of the AP-2 heterotetramer.
Interestingly, this substitution phenomenon does occur naturally to a limited extent, as incorporation of endogenous ␤2
into AP-1 in brain and ␤1 into AP-2 in liver has been documented (Page and Robinson, 1995; Sorkin et al., 1995; Traub
et al., 1996), and some ␤1 subunit is present in AP-2 immunoprecipitated from ⫹/⫹ fibroblasts (Figure 5A).
Simultaneous Knockdown of ␤1 and ␤2 Subunits
Functionally Ablates AP-2
Because gene silencing of the ␤2 subunit alone is insufficient
to reduce AP-2 levels and disrupt sorting, we designed an
siRNA duplex to extinguish the ␤1 subunit. Transfection of
this duplex selectively targets the ␤1 subunit, and together
the ␤1 ⫹ ␤2 subunit siRNAs silence both AP-1 and AP-2
(Figure 6A). Furthermore, the combined ␤1 ⫹ ␤2 RNAi
reproduces the ␣ subunit knockdown phenotype (Figure 6,
B–D). Morphologically, the level of the AP-2 ␣ subunit is
decreased by ␤1 ⫹ ␤2 subunit RNAi similar to that observed
with an ␣ subunit knockdown (Figure 6B), and the amount
of clathrin deposited on the plasma membrane is reduced to
that observed with the ␣ subunit RNAi (Figure 6C). Most
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importantly, transferrin receptor internalization is strongly
blocked and fluorescent transferrin accumulates in a diffuse
pattern over the cell surface (Figure 6D). Thus, simultaneous
knockdown of both ␤1 and ␤2 subunits functionally incapacitates AP-2 and phenocopies AP-2 ␣ or 2 subunit ablation.
Functional Reconstitution of AP-2 with ␤2-YFP
To begin to probe the function of the ␤2 subunit in vivo then,
an siRNA-insensitive ␤2 subunit fused at the carboxy terminus to YFP (␤2-YFP) (Sorkina et al., 2002; Hamdan et al.,
2007) was ectopically expressed in HeLa SS6 cells also transfected with the ␤1 ⫹ ␤2 subunit-silencing duplexes. The
transiently expressed ␤2 construct (Figure 7A) clearly reconstitutes AP-2 function successfully; the ectopic ␤2-YFP targets to ␣ subunit puncta in control cells, and restores normal
concentration of surface transferrin at clathrin-coated structures in ␤1 ⫹ ␤2 subunit knockdown cells (Figure 7, B and
C). Approximately 95% of ␤2-YFP– expressing cells display
clustered transferrin, whereas ⬍30% of the non-GFP–producing cells have similar patches of the ligand (Supplemental Figure S1B). Expression of the plasmid-borne YFP-tagged
␤2 subunit in some siRNA-treated cells is confirmed by
immunoblot (Figure 7A). The relatively low level of ␤2-YFP
expression (reflecting the transfection efficiency) concurs
with another recent study dealing with re-expression of a
GFP-tagged AP-2 ␣ subunit after RNAi (Rappoport and
Simon, 2008). Transfected cells have apparently normal
AP-2 levels, as seen by immunofluorescence, and permit
efficient transferrin internalization (Figure 7D); only ⬃20%
of ␤1 ⫹ ␤2 RNAi-treated cells not expressing GFP show
bright AP-2–positive puncta compared with ⬃70% of cells
synthesizing ␤2-YFP (Supplemental Figure S1B). Importantly, transferrin uptake is not the result of reduced siRNA
transfection efficiency due to the simultaneous addition of
␤2-YFP plasmid DNA during RNAi treatment. Adding similar amounts of control GFP plasmid DNA restores neither
AP-2 levels nor the punctate surface transferrin localization
(Supplemental Figure S2). Therefore, the ␤2-YFP seems to
functionally reconstitute AP-2 in ␤1 ⫹ ␤2 subunit knocked
down cells. Fused to YFP, a ␤2 subunit trunk that lacks the
C-terminal hinge and appendage, also targets to transferrinpositive puncta in control cells (Figure 7E), and it promotes
the clustering of surface transferrin at YFP-positive patches,
as opposed to the diffuse distribution of transferrin in neighboring ␤1- ⫹ ␤2-extinguished cells (Figure 7F).
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ARH Requires the ␤2 Appendage for Clathrin Coat
Localization
Next, we examined the effects the ␤1 ⫹ ␤2 subunit knockdown has on the distribution of the ␤2 subunit binding
partner ARH. ARH uses a helically structured [DE]nX12FXX[FL]XXXR motif to engage the platform site on the ␤2
appendage (Edeling et al., 2006a; Schmid et al., 2006). Knockdown of the ␤1 ⫹ ␤2 subunits reduces the amount of ARH
localized to clathrin-coated structures (Figure 8). This can be
reversed by expression of the ␤2-YFP, but not ␤2-YFPTRNK
lacking both the unstructured hinge and appendage domains (Figure 8, A and B). This failure to rescue is due solely
to lack of a functional platform binding site, as expression of
␤2-YFP bearing the platform site-disrupting Y888V mutation fails to restore ARH localization, but simultaneous deletion of the clathrin box and introduction of the sandwich
site disrupting Y815A mutation into ␤2-YFP reconstitutes
ARH positioning in clathrin coats (Figure 8, C and D). Measurement of the difference in fluorescence intensity between
transfected cells and neighboring knockdown cells demonstrates that the AP-2 dependence of ARH coated-structure
localization is wholly dependent on the ␤2 appendage platform site (Figure 8E). We conclude that in vivo ARH requires the ␤2 appendage binding sequence to efficiently
target to clathrin coats to promote efficient sorting of LDL
receptors.

Figure 5. Stable incorporation of the ␤1 subunit into AP-2 in ␤2
subunit-null mouse fibroblasts. (A) Aliquots of lysates from either
control ⫹/⫹ (lane a) or ␤2-null ⫺/⫺ (lane c) mouse embryonic
fibroblasts and of mAb AP.6 immunoprecipitates from the ⫹/⫹
(lane b) or ⫺/⫺ (lane d) lysates were resolved by SDS-PAGE and
transferred to nitrocellulose. Blots were probed with anti-clathrin
HC mAb TD.1 and affinity purified anti-␤1/␤2 subunit polyclonal
GD/1, anti-AP-2 ␣ subunit mAb clone 8, anti-AP-2 2 subunit
antiserum, or affinity-purified anti-1 subunit polyclonal RY/1, and
only the relevant portion of each blot is shown. The asterisk indicates a nonspecific band. Loss of ␤2-chain expression results in a
compensatory increase in the steady-state level of the ␤1 subunit in
the cultured fibroblasts, although the level of AP-2 is nevertheless
reduced compared with wild-type fibroblasts. (B–E) Wild-type
(⫹/⫹; left column) or ␤2-null (⫺/⫺; right column) mouse embryonic fibroblasts were fixed and labeled with Hoechst 33258, anti-␣
subunit mAb AP.6 and either anti-␤1/␤2 subunit GD/1 (B), antiDab2 (C), anti-epsin (D), or anti-eps15 (E) polyclonal antibodies.
Representative confocal sections of the ventral plasma membrane
are shown. In all cases, absence of ␤2 does not obviously perturb the
punctate patterning of the ␣ subunit or CLASPs. Bar, 10 m.
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Clathrin Binding Surface on the ␤2 Subunit Appendage
In addition to engaging ARH and ␤-arrestins, the ␤2 subunit
appendage also binds physically to clathrin (Owen et al.,
2000; Lundmark and Carlsson, 2002; Edeling et al., 2006a;
Knuehl et al., 2006; Schmid et al., 2006). Yet, the precise
molecular basis for this association is currently controversial. There is general agreement that by binding bivalently to
the clathrin heavy chain, some ␤2 subunit partners could be
controlled spatiotemporally as the extent of polymerized
clathrin lattice increases (Edeling et al., 2006a; Knuehl et al.,
2006; Schmid et al., 2006; Schmid and McMahon, 2007; Ungewickell and Hinrichsen, 2007). We recently mapped the
clathrin binding surface to a site, including Tyr815, on the
N-terminal sandwich subdomain (Edeling et al., 2006a), and
our prior results indicate that clathrin binding to the ␤2
appendage sandwich can displace interaction partners such
as eps15 and AP180, which bind to the same site. Because
clathrin trimers stoichiometrically outnumber AP-1/2 in
preparations of biochemically purified clathrin-coated vesicles (Blondeau et al., 2004; Girard et al., 2005), the excess of
clathrin heavy chain terminal domains, which project into
the interior of the assembled coat (Musacchio et al., 1999;
Edeling et al., 2006b), can bind avidly to AP-2 through the ␤2
subunit. Indeed, we (Edeling et al., 2006a) and others (Tebar
et al., 1996) localize eps15 to only the periphery of clathrincoated structures. Similar conclusions have been drawn for
the mode of engagement of the monomeric GGA adaptor
proteins and clathrin, where the C-terminal GAE domain of
the GGAs only contains a sandwich subdomain (Knuehl et
al., 2006). Because activation of GPCRs leads to the rapid
translocation of an activated GPCR䡠␤-arrestin complex to
pre-existing clathrin-coated structures at the cell surface (Laporte et al., 2000; Santini et al., 2002; Scott et al., 2002), and
because ARH (Figure 8; He et al., 2002; Mishra et al., 2002b)
and ␤-arrestins (Kim and Benovic, 2002; Laporte et al., 2002)
specifically engage the platform subdomain of the ␤2 appendage, we proposed that the ␤2 platform interaction surface represents a relatively privileged binding site (Mishra et
al., 2005; Brett and Traub, 2006; Edeling et al., 2006a). ChalMolecular Biology of the Cell
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Figure 6. ␤1 ⫹ ␤2 subunit RNAi recapitulates ␣ subunit RNAi phenotype. (A) Lysates of HeLa SS6 cells
untreated (lane a) or treated with either AP-1 ␤1 (lane
b), AP-2 ␤2 (lane c), or ␤1 ⫹ ␤2 subunit siRNAs (lane d)
were resolved by SDS-PAGE and either Coomassie
stained or transferred to nitrocellulose. Sections of the
blots were probed with the anti-clathrin HC mAb TD.1
and anti-␤1/␤2 subunit mAb 100/1, anti-AP-2 ␣ subunit mAb clone 8, anti-AP-2 2 subunit antiserum, antiAP-1 ␥ subunit antibody AE/1, or anti-AP-1 1 subunit
antibody RY/1 polyclonal antibodies, and only the relevant portions are shown. The position of molecular
mass standards (in kilodaltons) is indicated on the left.
(B–D) HeLa SS6 cells were either untreated (left),
treated with either AP-2 ␣ subunit siRNA (middle), or
both AP-1 ␤1 and AP-2 ␤2 subunit siRNA (right). Next,
they were either fixed and probed with anti-AP-2 ␣
subunit mAb AP.6 (B), brefeldin treated and permeabilized on ice before fixation and probed with anti-clathrin
HC mAb X22 (C), or serum starved for 1 h, given 25
g/ml Tf568 continuously for 15 min at 37°C, and fixed
(D). Arrowheads indicate accumulation of transferrin on
the cell surface in contrast to the control cells. Bar, 10 m.

lenging these findings and calling our conclusions “misleading,” McMahon and colleagues assert that it is the platform
subdomain, and not the sandwich site, that is the location of
the second point of contact between the clathrin heavy chain
and the ␤2 (and ␤1) hinge ⫹ appendage (Schmid et al., 2006;
Schmid and McMahon, 2007). In this model, clathrin interference dislodges CLASPs such as ␤-arrestin and ARH from
the ␤2 appendage, but because both these proteins also have
an adjacent but separate clathrin binding sequence, the proteins would remain associated with assembling clathrin
coats despite occupancy of the ␤2 platform with a distal leg
segment of the heavy chain (Schmid et al., 2006; Schmid and
McMahon, 2007). This is a chief feature of the changing hubs
model formulated to account for the vectorial nature of the
clathrin coat assembly process (Schmid and McMahon,
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2007). Clearly then, these opposing models have importantly
different implications for the molecular basis of ARH- and
␤-arrestin–mediated cargo capture within forming clathrin
coats.
To attempt to distinguish between the two models, we
used a mutant form of ␤-arrestin 1. Wild-type ␤-arrestins
remain diffusely cytosolic in the absence of GPCR stimulation (Laporte et al., 2000; Santini et al., 2002; Scott et al., 2002)
(Figure 9A) by maintaining a basal, inactive conformation.
Several closely spaced residues within the C-terminal
[DE]nX1-2FXX[FL]XXXR motif interact with the major folded
N-terminal region of ␤-arrestin, rigidifying the protein and
attenuating the CLASPs ability to engage the assembling
clathrin machinery (Kim and Benovic, 2002; Gurevich and
Gurevich, 2004; Edeling et al., 2006a; Burtey et al., 2007). In
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Figure 7. Rescue of AP-2 knockdown with ␤2-YFP. (A) Lysates of HeLa SS6 cells untreated (lane a) or treated with either AP-2 ␣ subunit
(lane b), both AP-1 ␤1 subunit and AP-2 ␤2 subunit siRNA (lane c) along with full-length ␤2-YFP (lane d), or ␤2-YFPTRNK (lane e) were
resolved by SDS-PAGE and transferred to nitrocellulose. Sections of the blots were probed with the anti-clathrin HC mAb TD.1 and
anti-␤1/␤2 subunit mAb 100/1, anti-GFP antibody, anti-AP-2 ␣ subunit mAb clone 8, anti-AP-2 2 subunit antiserum, or anti-AP-1 ␥ subunit
antibody AE/1 and only the relevant portions show. (B–F) Mock-transfected (B and E) or ␤1 ⫹ ␤2 subunit siRNA-transfected (C, D, and F)
HeLa SS6 cells were transfected with either full-length ␤2-YFP (B–D) or ␤2-YFPTRNK (E and F) (green in merged images), and either surface
labeled with Tf568 (B, C, E, and F) (red in merged images) and fixed, or incubated with Tf568 continuously for 15 min at 37°C, fixed, and
probed with anti-AP-2 ␣ subunit mAb AP.6 (D) (blue in merged image). Note that ␤2-YFP– expressing cells cluster transferrin at the surface
(C) and do not have the typical circumferential band of transferrin at 15 min (D; arrowheads) and that the ␤2-YFPTRNK restores clustering
of surface transferrin receptors (F) as well. Bar, 10 m.

␤-arrestin 1, immediately preceding the proximal Phe388 of
the ␤2 platform binding motif are Ile386 and Val387. Double
substitution of these residues to Ala (IV3 AA) results in
constitutive association of ␤-arrestin 1 with clathrin-coated
structures in the absence of any GPCR activation (Burtey et
al., 2007). If ␤-arrestins only remain associated with surface
coated structures by switching to clathrin when assembling
clathrin binds the AP-2 ␤2 subunit appendage, then deletion
or mutation of the ␤-arrestin 1 clathrin box sequence
376
LIELD should prevent the IV3 AA mutant from colocalizing extensively with clathrin-coated structures at the
plasma membrane.
Using TIR-FM to inspect the ventral surface of HeLa SS6
cells stably expressing ␤2-YFP, we confirm that tdRFP-␤arrestin 1 is soluble while a portion of the IV3 AA mutant
concentrates at pre-existing, ␤2 subunit positive clathrincoated structures (Figure 9, A and B) (Burtey et al., 2007). In
the IV3 AA background, the colocalization of neither a
LIEL3 AAEA substitution nor a ⌬LIELD mutant with
coated structures at the plasma membrane marked by ␤2YFP is obviously different from the protein containing an
intact clathrin box (Figure 9, C and D). Although 0.6 ⫾ 0.3%
of AP-2 structures colocalize with tdRFP-␤-arrestin 1, 99.1 ⫾
0.6% of AP-2–positive spots contain tdRFP-␤-arrestin
(IV3 AA). For the tdRFP-␤-arrestin (IV3 AA⫹LIEL3 AAEA)
and tdRFP-␤-arrestin (IV3 AA⫹⌬LIELD) mutants, 95 ⫾ 2%
and 89 ⫾ 3% of AP-2 structures contain ␤-arrestin, respectively.
There are several distinct classes of clathrin-coated structures on the ventral surface of HeLa SS6 cells (Keyel et al.,
2004), and the IV3 AA ␤-arrestin 1 mutants localize to all of
these. Analysis of the dynamics of de novo-forming puncta
reveals that, like the tdRFP-␤-arrestin 1 (IV3 AA) (Figure 10,
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A–C), the IV3 AA⫹⌬LIELD mutant concentrates at, and
then disappears with, ␤2-YFP–tagged AP-2 structures (Figure 10 D–F). We do not observe earlier loss of the
IV3 AA⫹⌬LIELD tdRFP-␤-arrestin 1 mutant from these
patches that would indicate failure to switch to a strictly
clathrin-dependent mode of association. Very similar results
are obtained using BS-C-1 cells stably expressing GFPtagged clathrin light chain (data not shown), a cell line that
exhibits de novo coat formation almost exclusively (Ehrlich
et al., 2004).
It is important to note that in these experiments, the
activation of the ␤-arrestin 1 (IV3 AA) mutant occurs in the
absence of any GPCR ligand addition, but HeLa SS6 cells
also do express endogenous ␤-arrestins. Although there is
currently some doubt that nonvisual arrestins oligomerize at
physiological concentrations (Hanson et al., 2008b), overexpressed ␤-arrestins can form multimers (Storez et al., 2005;
Milano et al., 2006). Oligomerization requires inositol
hexakisphosphate binding and pertains to the soluble form
of ␤-arrestin, because the contact sites for dimer and tetramer assembly are located on the concave surface that
engages an activated receptor (Milano et al., 2006; Hanson et
al., 2008a,b). Solution oligomers therefore do not bind to
GPCRs, and exposure of the C-terminal region, which couples ␤-arrestins to the clathrin machinery, destabilizes oligomers (Hanson et al., 2008a). We thus believe it unlikely
that hetero-oligomerization with endogenous ␤-arrestins accounts for the association of the IV3 AA ⫹ clathrin box
mutants with surface clathrin-coated structures. Supporting
this view is that transfection of the tdRFP-␤-arrestin 1
(IV3 AA) clathrin-binding mutants into ␤-arrestin 1/2 nullizygous fibroblasts (Kohout et al., 2001) still results in constitutive
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Finally, like the ␤-arrestin 1 (IV3 AA) mutant, the compound (IV3 AA⫹⌬LIELD) mutant translocates rapidly to
the surface of angiotensin II-stimulated HEK cells stably
expressing the type I angiotensin II receptor (Figure 12). At
5 min, both the ␤-arrestin mutants colocalize with fluorescent angiotensin II at cell surface patches and peripheral
endosomes, whereas, after 20 min, both angiotensin II and
␤-arrestin 1 (IV3 AA⫹⌬LIELD) are found in larger, juxtanuclear endosomes, typical of a class B GPCR (Hamdan et
al., 2007). These results show that deletion of the ␤-arrestin
clathrin box does not have a major negative affect on GPCR
down-regulation and are fully consistent with a doubly
mutated IV3 AA⫹LIEF3 AAEA ␤-arrestin 2 mutant clustering activated thyrotropin-releasing hormone receptors at
AP-2–positive clathrin-coated structures and orchestrating
endocytic uptake roughly equivalent to wild-type ␤-arrestin
2 at 10 min (Burtey et al., 2007). We conclude that ␤-arrestin
switching to a clathrin-dependent mode of association is not
an obligate step during the formation of clathrin-coated
vesicles and that the [DE]nX1-2FXX[FL]XXXR binding surface upon the platform subdomain of the ␤2 appendage does
represent a privileged interaction site, because it can be
rapidly accessed by ARH or ␤-arrestin in the face of ongoing
endocytic activity.
DISCUSSION

Figure 8. ARH requires the ␤2 appendage platform for plasma
membrane localization. HeLa SS6 cells transfected with ␤1 ⫹ ␤2
subunit siRNAs and either full-length ␤2-YFP (A), ␤2-YFP trunk (B),
or full-length ␤2-YFP bearing Y888V (C), or dual Y815A and
⌬LLNLD (D) mutations (left column) were incubated with 50
g/ml Tf633 for 15 min at 37°C, permeabilized, fixed and stained
with polyclonal anti-ARH antibodies (right column). (E) A comparison of the fluorescence intensity between ␤2-YFP–transfected cells
and knockdown cells (as determined by lack of Tf633 internalization) shows the differences between ␤2-YFP fusions that can recruit
ARH to the membrane and those that cannot. No rescue indicates
the difference in ARH intensity between wild-type and ␤1 ⫹ ␤2
knocked down cells.

accumulation of the tagged ␤-arrestin at membrane puncta that
are also positive for surface transferrin (Figure 11).
Vol. 19, December 2008

AP-2 ablation has a major inhibitory effect on the surface
clustering and internalization of YXXØ-bearing proteins and
also [DE]XXXL[LIM] (McCormick et al., 2005)-bearing proteins. This confirms the chief sorting activity that this adaptor complex confers. Yet, at least in cultured cells, AP-2
silencing is still compatible with internalization of a subset
of clathrin-dependent cargo; several groups have now
shown this phenomenon independently (Hinrichsen et al.,
2003; Motley et al., 2003; Barriere et al., 2006; Keyel et al.,
2006; Maurer and Cooper, 2006; Eden et al., 2007). The same
is not true if clathrin levels are decreased by RNAi (Hinrichsen et al., 2003; Motley et al., 2003; Moskowitz et al., 2005;
Barriere et al., 2006; Keyel et al., 2006; Maurer and Cooper,
2006). Careful single cell analysis of clathrin knocked down
populations reveals that rates of endocytosis become severely slowed when clathrin triskelia begin to be limiting
(Moskowitz et al., 2005). This difference indicates to us that
although clathrin is essential for the fabrication of budding
vesicles, AP-2 can be replaced to some extent by other clathrin-binding CLASPs such as Dab2, epsin, eps15, ARH,
stonin 2, HIP1/Hip1R, and CALM. Correct surface deposition of Dab2 still permits clustering of LDL receptors when
AP-2 is silenced; even though ARH depends upon AP-2 for
proper placement in surface clathrin structures, ARH and
Dab2 are functionally redundant and robust LDL uptake
persists in either Dab2- or ARH-lacking HeLa cells (Keyel et
al., 2006; Maurer and Cooper, 2006; Eden et al., 2007). The
clathrin-, PtdIns(4,5)P2- and cargo-binding qualities of Dab2
and other CLASPs likely accounts for the preservation of
clathrin-coated vesicle formation in an AP-2 compromised
background. Still, our ultrastructural analysis of cell membranes under these conditions shows that the clathrin lattices are not of normal dimensions, although invaginating
buds are evident. The two AP-2 appendages operate as
interaction hubs that can engage ⬎20 CLASPs and accessory
factors (Wang et al., 1995; Traub, 2005; Edeling et al., 2006b;
Maldonado-Baez and Wendland, 2006; Schmid and McMahon, 2007), including type I phosphatidylinositol 4-phosphate 5-kinases (Bairstow et al., 2006; Krauss et al., 2006;
Nakano-Kobayashi et al., 2007) and the PtdIns(4,5)P2 phos5319
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Figure 9. Clathrin-binding deficient ␤-arrestin 1 associates with AP-2. HeLa SS6 cells stably expressing ␤2-YFP were transiently transfected
with wild-type (WT) tdRFP-␤-arrestin 1 (A), tdRFP-␤-arrestin 1 with the IV3 AA activating mutation (B), or tdRFP-␤-arrestin 1 (IV3 AA) ⫹
clathrin box mutation LIEL3 AAEA (C) or ⫹ clathrin box deletion ⌬LIELD (D). Approximately 18 h after transfection, cells were imaged by
TIR-FM to selectively observe the ventral surface. Representative images show tdRFP-␤-arrestin 1 (left column), ␤2-YFP (middle column), and
merged (right column) signals. Note that despite a considerable cytosolic pool, there is near complete colocalization of ␤2-YFP puncta with
the tdRFP-␤-arrestin 1 (IV3 AA) alone or with either clathrin box disruption. Bar, 10 m.

phatases synaptojanin 1 (Haffner et al., 2000; Jha et al., 2004)
and OCRL (Ungewickell et al., 2004). Given the vital role that
PtdIns(4,5)P2 plays in clathrin-coated vesicle assembly and
budding at the plasma membrane, we suspect the residual
5320

AP-2 we see in cells subject to siRNA knockdown probably
contributes to LDL uptake. Our overall interpretation of the
available data is that clathrin-coated structures never
evolved to operate in the absence of AP-2, and is fully
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Figure 10. Clathrin-binding deficient ␤-arrestin 1 dynamically associates with AP-2. HeLa SS6 cells stably expressing ␤2-YFP were
transiently transfected with tdRFP-␤-arrestin 1 (IV3 AA) (A–C) or tdRFP-␤-arrestin 1 (IV3 AA⫹⌬LIELD) (D–F). Approximately 18 h after
transfection, cells were imaged by TIR-FM at one frame every 5 s. (A) Representative frames from the tdRFP-␤-arrestin 1 (IV3 AA)–
expressing cells. ␤-arrestin 1 (left frame) and ␤2-YFP (middle frame) show extensive colocalization (right frame). (B) A sequence of frames
at 25-s intervals shows the simultaneous disappearance of tdRFP-␤-arrestin 1 (IV3 AA) (middle row) and ␤2-YFP (bottom row) from the
evanescent field. The spot is the same as that boxed in A. (C) A line drawn along the axis of the box in A was used to create a kymograph.
tdRFP-␤-arrestin 1 IV3 AA (left column) and ␤2-YFP (middle column) leave the evanescent field together (right column). (D) tdRFP-␤arrestin 1 (IV3 AA⫹⌬LIELD)– expressing cells likewise show significant overlap with ␤2-YFP as in depicted in A. (E) The boxed spot in D
containing tdRFP-␤-arrestin 1 (IV3 AA⫹⌬LIELD) (middle row) and ␤2-YFP (bottom row) disappears from the field (solid arrowhead) at
100 s as a second spot containing both proteins appears (open arrowhead). (F) A line drawn along the axis of the box in D was used
to create a kymograph. tdRFP-␤-arrestin 1 (IV3 AA⫹⌬LIELD) (left column) and ␤2-YFP (middle column) disappear together, whereas
the appearance of arrestin in the second spot is slightly preceded by ␤2-YFP. All horizontal bars, 10 m (A and D); vertical time bars,
60 s (C and F).

consistent with the lethal consequence of interfering with
expression of certain AP-2 adaptor subunits in C. elegans
(Grant and Hirsh, 1999; Shim and Lee, 2000; Kamikura and
Cooper, 2003), Drosophila (Gonzalez-Gaitan and Jackle, 1997),
Vol. 19, December 2008

and mice (Mitsunari et al., 2005). Harder to explain is the
completely normal internalization rate of a CD8-LDL receptor
chimera in HeLa cells containing ⬍10% of the surface clathrin
structures observed in AP-2 replete cells (Motley et al., 2003).
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Figure 11. Clathrin-binding deficient ␤-arrestin
1 associates with clathrin-coated structures in the
absence of endogenous ␤-arrestins. Wild-type
and ␤-arrestin 1/2 null mouse embryonic fibroblasts were lysed and resolved by SDS-PAGE (A;
left) and transferred to nitrocellulose (A; right).
Portions of the blots were probed with an anti␤-arrestin polyclonal antibody, anti-clathrin HC
mAb TD.1, and anti-␤1/␤2 subunit mAb 100/1,
or with anti-tubulin mAb E7. The position of the
molecular mass standards (in kilodaltons) is
noted on the left. Alternatively, ␤-arrestin 1/2
null mouse embryonic fibroblasts were transiently transfected with tdRFP-␤-arrestin 1 (red)
wild type (B), the tdRFP-␤-arrestin 1 (IV3 AA)activating mutation (C), IV3 AA ⫹ clathrin box
mutation LIEL3 AAEA (D), or IV3 AA ⫹ clathrin box deletion ⌬LIELD (E). At 18 h after transfection, cells were incubated with 25 g/ml
Tf488 (green) on 4°C on ice for 1 h to label transferrin receptor in clathrin-coated structures, and
then they were rapidly imaged at 17°C by TIRFM. Under these conditions, transferrin is found
both at clathrin coated structures on the cell surface and already in peripheral endosomes. Magnified insets are denoted by white boxes; the
IV3 AA and IV3 AA ⫹ clathrin box disruption
␤-arrestin mutants (middle inset) both colocalize
with Tf488 (top inset), as denoted by arrowheads.
Bar, 10 m.

Because of the high degree of sequence identity between
the adaptor ␤1 and ␤2 subunits, gene silencing or targeted
gene disruption of the ␤2 subunit results in only a moderate
endocytic phenotype. ␤2 is probably the only subunit of
AP-2 that can be replaced by an AP-1 counterpart, because
the 1 subunit does not interact directly with the ␣ subunit
(Page and Robinson, 1995), and 2 subunit RNAi phenocopies the ␣ subunit RNAi (Motley et al., 2003; Huang et al.,
2004). We suspect that the opposite is also true, because it is
known that ␤2 subunits can incorporate into AP-1 in vivo
(Page and Robinson, 1995; Sorkin et al., 1995; Traub et al.,
1996). Also, at moderately high levels, ectopically expressed
␤2-YFP can incorporate into AP-1 (Huang et al., 2003; Keyel
et al., 2004), and the C-terminal region of ARH interacts
similarly with AP-1 and AP-2 but not with AP-3 (He et al.,
2002; Mishra et al., 2002b). All of the key specificity-determining residues at the platform and sandwich subdomain
interaction interfaces are conserved between the ␤1 and ␤2
5322

polypeptides. This must account for the functional activity
of a hybrid AP-2 incorporating a ␤1 chain. The apparent
interchangeability of the ␤1 and ␤2 subunits, the localization
of some eps15 at a juxtanuclear, TGN-like location (Tebar et
al., 1996; Kent et al., 2002), and our detection of the ␤-arrestin
1 (IV3 AA) mutant at the juxtanuclear/TGN region (Figure
12) raises the question of whether known AP-2 ␤2 binding
partners also function normally together with AP-1. A very
recent study in fact mapped an apparent AP-1–specific binding site on eps15 to the sequence 720ESFDGDFADFSTLS (Chi
et al., 2008). Remarkably, this region is identical to a peptide
segment of eps15 cocrystallized at the sandwich site of the
AP-2 ␤2 appendage (Schmid et al., 2006). The reason why
deletion of this amino acid tract from eps15 perturbs only
AP-1 binding (Chi et al., 2008) is because the proximal
tract of ⬎10 DPF triplets facilitates AP-2 engagement
through interaction with the platform subdomain of the ␣
subunit appendage (Owen et al., 1999; Brett et al., 2002);
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Figure 12. Down-regulation of the type 1 angiotensin II receptor by both tdRFP-␤-arrestin 1
(IV3 AA) and ␤-arrestin (IV3 AA⫹⌬LIELD).
HEK293 cells stably expressing FLAG-tagged
type I angiotensin II receptor were transiently
transfected with tdRFP-␤-arrestin 1 (IV3 AA)
(A), or tdRFP-␤-arrestin 1 (IV3 AA⫹⌬LIELD)
(B). Cells were starved for 1 h in starvation medium and then stimulated with 100 nM angiotensin II conjugated to Alexa488 (AngII; green) for 0,
5, or 20 min. Cells were washed, fixed, and examined by confocal microscopy. Representative
images of medial focal planes are shown. Before
stimulation, ␤-arrestin is largely diffuse in the
cytosol but also present at the plasma membrane
(arrows) or at a juxtanuclear location (asterisks).
After 5 min of stimulation, ␤-arrestin clusters
with angiotensin II at the plasma membrane
(closed arrowheads), and on endosomes (open
arrowheads). At 20 min after stimulation, nearly
all ␤-arrestin and angiotensin II colocalize on
larger endosomes. Bar. 10 m.

the appendage of the analogous subunit in AP-1, the ␥
subunit, lacks a platform subdomain, and binds eps15
only very weakly (Kent et al., 2002; Nogi et al., 2002). The
fact that overexpression of an eps15 mutant lacking the
above-mentioned 14-amino acid ␤-binding tract sharply
slows exit of the MPR from the TGN (Chi et al., 2008)
argues that the ␤1 and ␤2 subunits do perform some
similar functions at the TGN/endosome and plasma
membrane, respectively.
Because eps15 contacts the ␤2 appendage through the
sandwich subdomain, a mutation that disrupts this interaction surface interferes with eps15 binding (Edeling et al.,
2006a; Schmid et al., 2006). We find that this same mutation
(Y815A) abolishes clathrin binding, indicating that eps15
and clathrin compete for a common site on the ␤2 appendage sandwich subdomain (Edeling et al., 2006a). Biochemical
experiments show plainly that eps15 preloaded onto AP-2 is
expelled upon clathrin assembly and eps15 fails to be incorporated along with AP-2 into assembled clathrin coats (Cupers et al., 1998). By contrast, ARH and the ␤-arrestins differ
significantly from eps15 and several other CLASPs and accessory factors in that they both display only a single AP-2
binding determinant with an absolute selectivity for the
platform subdomain of the ␤2 appendage (Laporte et al.,
2000; He et al., 2002; Mishra et al., 2002b). Substantial data
attest to the critical and selective importance of the ␤2 appendage in the initial recruitment of GPCR䡠␤-arrestin complexes to pre-existing sites of clathrin assembly. The clathrin
box is located within a flexible, unstructured C-terminal
loop (Milano et al., 2002), even in the basal ␤-arrestin conformation. Yet ␤-arrestins are cytosolic in the absence of
GPCR activation (Hamdan et al., 2007), so, although the
clathrin box is potentially accessible to the clathrin terminal
domain, if the distal [DE]nX1-2FXX[FL]XXXR sequence is
conformationally restrained, ␤-arrestins fail to associate appreciably with clathrin-coated structures. Similarly, when
fused to GFP, the C-terminal region of ␤-arrestin 2 populates
AP-2–positive clathrin structures at the cell surface but this
colocalization is completely lost if the [DE]nX1-2FXX[FL]XXXR sequence is disrupted, even with an intact adjacent clathrin box (Schmid et al., 2006). Also, the ␤-arrestin 1
IVF3 AAA triple mutant is not colocalized with AP-2 at
steady state, despite the conformation relaxation affected by
the IV to AA substitution (Burtey et al., 2007). Mutagenic
Vol. 19, December 2008

inactivation of the AP-2 binding sequence in ␤-arrestin 2 still
allows translocation of this CLASP to agonist-stimulated
GPCRs on the cell surface, but clustering at AP-2–positive
puncta is lost, again despite an intact clathrin box (Laporte et
al., 2000). Indeed, bioluminescence resonance energy transfer studies show that ␤-arrestin binding to liganded GPCRs
temporally precedes an AP-2 ␤2 appendage interaction
(Hamdan et al., 2007) and that mutation of the interaction
surface on the ␤2 platform subdomain prevents energy
transfer to AP-2 (Hamdan et al., 2007). By contrast, even with
an inactivating mutation or complete deletion of the clathrin
box, ␤-arrestin 1 still targets to clathrin-coated structures
(Figures 9 –12). Altogether, this argues strongly that the
[DE]nX1-2FXX[FL]XXXR sequence is the principal determinant governing initial linkage of GPCRs with the endocytic
machinery (Laporte et al., 2000).
Our siRNA/reconstitution experiments reveal that ARH
likewise uses the analogous interaction motif as the primary
mode of clathrin-coat engagement. In fact, simultaneous
gene silencing of AP-2 and Dab2 leads to stalling of the LDL
receptor at the cell surface despite normal ARH levels and
the clear presence of surface clathrin coats (Keyel et al., 2006;
Maurer and Cooper, 2006). The binding affinity of ARH (and
␤-arrestin) for the ␤2 appendage is greater than its affinity
for any other binding partner. ARH binds to the ␤2 appendage, with a KD value of ⬃1 M (Mishra et al., 2005), compared with 22 M for a type I clathrin box LLDLD binding
to clathrin (Miele et al., 2004), 10 –100 M for the Shc PTB
domain binding to PtdIns(4,5)P2 (Zhou et al., 1995), and 2–5
M for various PTB domains binding to FXNPXY peptides
(Li et al., 1998; Howell et al., 1999; Stolt et al., 2003; Stolt et al.,
2005). In a sequential hub model for clathrin-coated vesicle
assembly, it is proposed that AP-2– dependent interactions
are diminished as clathrin buds progress toward late-stage
events (Schmid et al., 2006; Schmid and McMahon, 2007). In
fact, it is conjectured that ARH and ␤-arrestins only remain
associated with deeply invaginated buds by interacting directly with clathrin heavy chains (Schmid et al., 2006). Given
the 10-fold difference in binding affinity for the ␤2 appendage and the clathrin terminal domain, which is also subject
to direct competition by numerous other CLASPs and accessory proteins that have tandemly repeated clathrin boxes
and are massed at the bud site (Robinson, 2004; Sorkin, 2004;
Maldonado-Baez and Wendland, 2006), the biological ad5323
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vantage of moving to an apparently lower affinity association (at the clathrin hub) is not obvious.
The changing hub model was formulated, in part, to account for the inherent directionality of the clathrin-coat assembly process (Schmid et al., 2006; Schmid and McMahon,
2007). Although our view is that CLASPs like ARH and
␤-arrestin, which associate physically with AP-2 through the
␤2 appendage, do not necessarily switch to a clathrin-dependent interaction mode in a temporally-defined manner,
our observations certainly do not generally invalidate the
model, which invokes changing degrees of freedom as a
function of ongoing lattice assembly events. Nor do our
findings indicate that the clathrin box in either ARH or
␤-arrestin is functionally insignificant (Krupnick et al., 1997;
Laporte et al., 2000; Kim and Benovic, 2002; Santini et al.,
2002; Garuti et al., 2005). Rather, our data agree with several
independent investigations showing the ␤-arrestin䡠AP-2 interaction typically initiates clustering of GPCRs into clathrin-coated structures and simply preclude ARH and ␤-arrestins from the set of potential endocytic factors subject to
displacement by assembling clathrin triskelia. Intriguingly,
because of the clear functional redundancy between the
adaptor ␤1 and ␤2 subunits, and because only a single pool
of cytosolic clathrin is used to construct all clathrin-coats
within the cell, use of neither the [DE]nX1-2FXX[FL]XXXR
motif nor the clathrin box will ensure translocation of ␤-arrestin or ARH to only those AP-2 and clathrin-containing
structures positioned at the cell surface. However, both the
␤-arrestins (Gaidarov et al., 1999; Milano et al., 2002) and
ARH (Mishra et al., 2002b) bind to PtdIns(4,5)P2, a lipid
concentrated in the inner leaflet of the plasma membrane.
The phenomenon of coincidence detection, involving simultaneous contacts with transmembrane cargo receptors, lipids, AP-2, and then clathrin, likely provides the necessary
selectivity. The striking translocation of the cytosolic pool of
␤-arrestin 1 upon angiotensin II application (Figure 12) is a
graphic demonstration of this avidity-based phenomenon.
Overall then, the ␤2 appendage of AP-2 represents one hub
within an intricate web of protein–protein interactions that
promotes selective cargo endocytosis by facilitating initial
CLASP recruitment.
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